Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery

Mise à jour : Il y a 4 ans
Référence : NCT00168818

Femme et Homme

Extrait

The objective of this study is to determine the comparative efficacy and safety of two oral regimens of dabigatran etexilate, compared to a standard subcutaneous regimen of enoxaparin, in prevention of venous thromboembolism in patients with primary elective total hip replacement surgery.


Critère d'inclusion

  • Thromboembolism ,Arthroplasty, Replacement, Hip


Liens